Welcome to the GHAPP Digital Hub

The Gastroenterology & Hepatology Advanced Practice Providers (GHAPP) is dedicated to developing educational programs, providing professional advancement services, and assembling resources for—and guided by—advanced practice providers (APPs).

The GHAPP Digital Hub is the place for all GI & Liver digital education for APPs. Here you will have access to podcasts and various short video modules.

bannershape

bgdots

bannershape

sectionimg

Faculty

Alison Moe

PA-C

Atlanta, GA, USA

Ann Moore

NP

Phoenix, AZ

Christina Hanson

FNP-C

South Denver Gastroenterology

Gabriella McCarty

NP-C

North Shore Gastroenterology

Tedra Gray

NP-C

Sinai Medical Group

Kimberly Orleck

PA-C

Atlanta Gastroenterology Associates

Podcasts

The Clinical Utility of Guselkumab in CD

Simplifying Access: Prior Authorization Part 1

Simplifying Access: Prior Authorization Part 2

Simplifying Access: Evolving Drug Distribution Channels

Webcasts

Navigating New Horizons: Evolutions of MASH Care

Post Conference MASH Highlights from AASLD

Post Conference MASH Highlights From ACG

Post Conference MASH Highlights From EASL

FAQ Video Modules

What Are the Most Critical Updates in Cirrhosis Research That Clinicians Should Be Aware Of?

How Can Healthcare Professionals Improve Patient Outcomes in Those with Cirrhosis?

How Does the Guselkumab Data Align With the STRIDE II Guidelines?

KOL Interview: Can You Discuss Any Recent Breakthroughs in the Management of Cirrhosis?

Journal Club Video Modules

Week 48 Efficacy of Guselkumab vs. Ustekinumab in Crohn’s Disease: Insights from GALAXI 2 & 3

Efficacy & Safety of Subcutaneous Guselkumab: 48-Week Results from the Phase 3 GRAVITI Study

Efficacy and Safety of Guselkumab in Ulcerative Colitis: Phase 3 QUASAR Maintenance Study Results

Guselkumab Efficacy & Safety in Moderate to Severe CD-GALAXI 2 & 3 Results

Medication Review Video Modules

What Are Guselkumab's Other FDA Indications and How Might That Affect Patient Care?

What Is the Efficacy of Guselkumab in Ulcerative Colitis and Crohn's Disease?

What Is the Safety Profile of Guselkumab in Ulcerative Colitis and Crohn's Disease?

How Is Guselkumab Dosed in IBD?

Publications

Latest Insights in Alcohol-Related Liver Disease and Alcoholic Hepatitis

Utilizing Machine Learning to Predict Liver Allograft Fibrosis by Leveraging Clinical and Imaging Data

Circulating Exosomal Proteins as New Diagnostic Biomarkers for Colorectal Cancer (EXOSCOL01): A Pilot Case-Controlled Study Focusing on MMP14 Potential

Acute Pancreatitis: Clinical and Morphologic Classification

sectionimg

dotimg

Download the app and start using it now

Download on the App Store

GET IT ON Google Play